Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Institution: IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) SOHO Italy 2022

Institution: IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) SOHO Italy 2022

Exciting advances in DLBCL: molecular characterization of subtypes & novel immunotherapeutic agents 1:12
Exciting advances in DLBCL: molecular characterization of subtypes & novel immunotherapeutic agents
Gerardo Musuraca • 24 Oct 2022
The content of VJHemOnc is intended for healthcare professionals